US 12060555
MicroRNA-33 inhibitors and use thereof in the treatment of pulmonary fibrosis
granted A61KA61K31/713A61P
Quick answer
US patent 12060555 (MicroRNA-33 inhibitors and use thereof in the treatment of pulmonary fibrosis) held by UNIVERSITY OF CONNECTICUT expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- UNIVERSITY OF CONNECTICUT
- Grant date
- Tue Aug 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/713, A61P, A61P9/10